Free Trial

Stocks Remain High Despite Pfizer Tweet Confirmed Not New

EQUITIES

Stocks remain at the best levels of the cash session despite tweet from Fox News' Edward Lawrence recapping already-known timelines from Pfizer.

Full Pfizer press release from July 27th is here, contains those exact dates and quantities cited in Fox News tweet: https://www.pfizer.com/news/press-release/press-re...

MNI London Bureau | +44 203-865-3809 | edward.hardy@marketnews.com
MNI London Bureau | +44 203-865-3809 | edward.hardy@marketnews.com

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.